mk8141

Small moleculeexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2007 (NCT00543413)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • mk8141
  • mk8141

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00543413Phase 2Oct 1, 2007Actelion, Merck
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ActelionFor profit1012007
MerckFor profit1112007
2 organizations
Page 1 / 1